Article info
PDFResearch ethics
Paper
The potential benefit of the placebo effect in sham-controlled trials: implications for risk-benefit assessments and informed consent
- Correspondence to Dr Franklin G Miller, Department of Bioethics, National Institutes of Health, 10 Center Drive, Bldg. 10, rm 1C118, Bethesda, MD 20892-1156, USA; FMiller{at}cc.nih.gov
Citation
The potential benefit of the placebo effect in sham-controlled trials: implications for risk-benefit assessments and informed consent
Publication history
- Received August 21, 2012
- Revised November 1, 2012
- Accepted November 19, 2012
- First published December 13, 2012.
Online issue publication
October 15, 2013
Article Versions
- Previous version (13 December 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/